title: The importance of supportive care in optimizing treatment outcomes of patients with advanced prostate cancer.
abstract: Optimal oncologic care of older men with prostate cancer, including effective prevention and management of the disease and treatment side effects (so-called best supportive care measures) can prolong survival, improve quality of life, and reduce depressive symptoms. In addition, the proportion of treatment discontinuations can be reduced through early reporting and management of side effects. Pharmacologic care may be offered to manage the side effects of androgen-deprivation therapy and chemotherapy, which may include hot flashes, febrile neutropenia, fatigue, and diarrhea. Nonpharmacologic care (e.g., physical exercise, acupuncture, relaxation) has also been shown to benefit patients. At the Georges Pompidou European Hospital, the Program of Optimization of Chemotherapy Administration has demonstrated that improved outpatient follow-up by supportive care measures can reduce the occurrence of chemotherapy-related side effects, reduce cancellations and modifications of treatment, reduce chemotherapy wastage, and reduce the length of stay in the outpatient unit. The importance of supportive care measures to optimize management and outcomes of older men with advanced prostate cancer should not be overlooked.
authors.affiliation: Department of Medical Oncology, Georges Pompidou European Hospital, Paris, France. florian.scotte@egp.aphp.fr
authors.forename: Florian
authors.initials: F
authors.lastname: Scotté
mesh_terms: D026881:Acupuncture; D000368:Aged; D000726:Androgen Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D003967:Diarrhea / Q000209:etiology / Q000503:physiopathology; D015444:Exercise; D005221:Fatigue / Q000209:etiology / Q000503:physiopathology; D019584:Hot Flashes / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D007902:Length of Stay; D008297:Male; D009503:Neutropenia / Q000209:etiology / Q000503:physiopathology; D010166:Palliative Care; D011471:Prostatic Neoplasms / Q000150:complications / Q000628:therapy*; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome; D015013:Yoga
chemical_list: D000726:Androgen Antagonists